Neuregulin 1-ErbB4-PI3K signaling in schizophrenia and phosphoinositide 3-kinase-p110δ inhibition as a potential therapeutic strategy

Amanda J. Law, Yanhong Wang, Yoshitatsu Sei, Patricio O'Donnell, Patrick Piantadosi, Francesco Papaleo, Richard E. Straub, Wenwei Huang, Craig J. Thomas, Radhakrishna Vakkalanka, Aaron D. Besterman, Barbara K. Lipska, Thomas M. Hyde, Paul J. Harrison, Joel E. Kleinman, Daniel R. Weinberger

Research output: Contribution to journal › Article › peer-review

92 Scopus citations

Fingerprint

Dive into the research topics of 'Neuregulin 1-ErbB4-PI3K signaling in schizophrenia and phosphoinositide 3-kinase-p110δ inhibition as a potential therapeutic strategy'. Together they form a unique fingerprint.

Medicine & Life Sciences